Adynamic bone disease in patients on maintenance dialysis: Clinical relevance, non-invasive diagnosis and preventive treatment;Die adynamische osteopathie bei dialysepatienten: Klinische bedeutung, nichtinvasive diagnose und praventivbehandlung

Nieren- und Hochdruckkrankheiten

Volumn 28, Issue 10, 1999, Pages 394-401

  Fournier, A ^a   Oprisiu, R ^a   Ghitu, S ^a   Said, S ^a   Ghazali, A ^a   Moriniere P ^a   El Esper, N ^a   Cohen Solal, M E ^a   Brazier, M ^a   Bouillon, R ^a   Pruna, A ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Adynamic bone disease; Clinical significance; Maintenance dialysis; Noninvasive diagnosis; Prevention

Indexed keywords

BONE DENSITY; BONE DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE ASSOCIATION; HUMAN; KIDNEY FAILURE; PARATHYROID HORMONE RELEASE; REVIEW;

EID: 0032707004     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Cohen Solal M.E., J.L. Sebrrt, B. Boudailliez, A. Marié, P. Marinière, J. Gueris, R. Bouillon, A. Fournier: Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J. Clin. Endocrinol. Metab. 73, 516-524 (1991).
2. Cohen Solal M.E., J.L. Sebert, B. Boudailliez, P.F. Westeel, P. Morinière, A. Marié, M. Garabedian, A. Fournier: Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment? Bone 13, 1-5 (1992).
3. Fournier A., P. Marinière, P. Hardy Yverneau, R. Oprisiu, A. Marié: Adynamic bone disease in patients with uremia. Curr. Opin. Nephrol. Hypertens. 3, 396-410 (1994).
4. Hercz G., Y. Pei, C. Greenwood, A. Manuel, C. Saiphoo, W.G. Goodman, G.V. Segre, S. Fenton, D.J. Sherrard: Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int. 44, 860-866 (1993).
5. Hercz G., D.J. Sherrard, W. Chau, Y. Pei: Aplastic osteodystrophy: follow-up after 5 years. J. Am. Soc. Nephrol. 5, 851 (1994).
6. Kuizon B.D., W.G. Goodman, H. Jüppner, I.B. Salusky: Diminished linear growth during intermittent Calcitriol therapy in children undergoing CCPD. Kidney Int. 53, 205-211 (1998).
7. Lepage R., L. Roy, J.H. Brossard, L. Rousseau, C. Dorais, C. Lazure, P. d'Amour: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin. Chem. 44, 805-809 (1998).
8. 3 intake. Emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 53, 93-101 (1989).
9. Pei T., G. Hercz, C. Greenwood, D. Sherrard, D. Segre, A. Manuel, C. Saiphoo, S. Fenton: Non-invasive prediction of aluminum bone disease in hemo-and peritoneal dialysis patients. Kidney Int. 41, 1374-1382 (1992).
10. Qi Q., M.C. Monier-Fayere, Z. Geng, H. Malluche: Predictive value of serum levels for bone turnover in patients on chronic maintenance dialysis. Am. J. Kidney Dis. 26, 622-631 (1995).
11. Quarles L.D., B. Lobaugh, G. Murphy: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J. Clin. Endocrinol. Metab. 75, 145-150 (1992).
12. Sebert J.L, A. Marié, J. Guéris, M.A. Hervé, P. Leflon, M. Garabedian, A. Smadja, A. Fournier: Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formation. Bone 6, 373-375 (1985).
13. Sherrard D.J., S. Oh, N.A. Maloney, O. Andress, J. Coburn: Renal osteodystrophy: classification, cause and treatment. In: Frame B., J.J. Potts Jr.: Clinical disorders of bone and mineral metabolism. Excepta Medica, Amsterdam 1983, 254-259.
14. Ureña P., M. Hruby, A. Ferreira, K.S. Ang, M.C. de Vernejoul: Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J. Am. Soc. Nephrol. 7, 506-512 (1996).
15. Ureña P., M.C. de Vernejoul: Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int. 55, 2141-2156 (1999).
16. Wang M., G. Hercz, D.J. Sherrard: Relationship between intact 1-84 PTH and histomorphometric parameters in dialysis patients without aluminium toxicity. Am. J. Kidney Dis. 26, 836-844 (1995).